跳至主要内容
临床试验/NCT01530295
NCT01530295Unknown不适用

Biochemical Recurrence Rate of Radical Prostatectomy Combined With Neoadjuvant and Adjuvant in Patients With High Risk Locallized Prostate Cancer

Hanjong Ahn1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2008年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
70
试验地点
1
主要终点
biochemical recurrence rate of Radical Prostatectomy Combined with Neoadjuvant and Adjuvant Chemotherapy in Patients with High Risk Prostate Cancer

研究概览

简要总结

Effect of Radical Prostatectomy Combined with Neoadjuvant and Adjuvant Chemotherapy in Patients with High Risk Prostate Cancer.

The purpose of this study is to evaluate whether neoajuvant and adjuvant docetaxel and prednisone are effective in the treatment of high risk localized prostate cancer.

详细描述

The purpose of this study is to evaluate whether neoajuvant and adjuvant docetaxel and prednisone are effective in the treatment of high risk localized prostate cancer.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Crossover
盲法
None

入排标准

性别
Male
接受健康志愿者

入选标准

  • Prostate Cancer
  • PSA > 20 OR
  • Clinical Stage > T2C OR

排除标准

  • 未提供

研究组 & 干预措施

contol

No Intervention

control group

干预措施: DOCETAXEL (Drug)

chemotherapy

Other

neoadjuvant chemotherapy

干预措施: DOCETAXEL (Drug)

结局指标

主要结局

biochemical recurrence rate of Radical Prostatectomy Combined with Neoadjuvant and Adjuvant Chemotherapy in Patients with High Risk Prostate Cancer

时间窗: 2 Years After RRP

次要结局

未报告次要终点

研究者

发起方
Hanjong Ahn
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Hanjong Ahn

Professor

Asan Medical Center

研究点 (1)

Loading locations...

相似试验